LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Clinical trials for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to shrink Hard-to-Treat tumors
Disease control Not yet recruitingThis early-stage study tests a new experimental drug called BC3195 combined with the approved immunotherapy pembrolizumab in people with advanced solid tumors that have spread. The main goals are to check safety, find the right dose, and see if the combination can shrink tumors. …
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Biocity Biopharmaceutics Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:25 UTC
-
New pill-and-shot combo targets hard-to-treat cancers with PTEN loss
Disease control Not yet recruitingThis study tests a new combination of two drugs (CVL237 tablets and serplulimab injection) in people with advanced solid tumors that have lost or have low levels of a protein called PTEN. The goal is to see if the combo can shrink or control the cancer. About 180 adults aged 18-7…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Convalife (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
New drug duo targets tough cancers in phase 2 trial
Disease control Not yet recruitingThis study tests a combination of two experimental drugs (GH21 and D-1553) in people with advanced solid tumors that have a specific genetic change called KRASG12C. The trial includes two groups: one for non-small cell lung cancer and another for other solid tumors, all in patien…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:06 UTC